Personalized neoantigen vaccine (investigational)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Personalized neoantigen vaccine (investigational), covering 2026-04-23 to 2026-04-23. Get the full timeline:
Most recent: Clinical Trial Update: Trial of a Personalized and Adaptive Neoantigen Dose-Adjusted Vaccine Concurrently With Pembrolizumab [Phase 1]